The fundamental discovery of this project is the identification of the alpha7-nicotinic acetylcholine receptor as a strong candidate gene for an inherited physiological dysfunction in schizophrenia. The scientific work of the past 10 year-funding period has led to: (1) discovery of the alpha7-nicotinic receptor's neurobiological role in an inhibitory deficit associated with schizophrenia, (2) the first genetic linkage of the inhibitory deficit, as well as schizophrenia itself, to the chromosome 15q14 locus of the alpha7-nicotinic receptor gene, (3) the first evidence for decreased expression of this receptor in the hippocampus of schizophrenics, (4) the first description of the complex genomic structure of the human alpha7-nicotinic receptor gene, and (5) the first evidence for co-dominant inheritance of inhibitory deficits in childhood-on set schizophrenia. This renewal application seeks to replicate the current findings of linkage of an inhibitory neurophysiological deficit (Aims 1 and 2), and then extend the findings to a broader phenotype based on neuropsychological evaluation of probands and their relatives who do or do not carry genetic risk (Aim 3) and to a broader range of illnesses that have been associated with the alpha7-nicotinic receptor locus, viz. childhood-onset schizophrenia and bipolar disorder (Aims 4 and 5). The initial study used a neurobiological phenotype, i.e., the P50 inhibitory deficit, to find genetic linkage; in the replication, this new genetic information will now be used, first to improve precision, and then to broaden the description of this phenotype. Schizophrenia and bipolar disorder are complex illnesses with multiple genetic and non-genetic elements. The goal of this project is elucidate one of these elements as they are discovered.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Research Project (R01)
Project #
5R01MH038321-20
Application #
6638962
Study Section
Special Emphasis Panel (ZRG1-BDCN-6 (01))
Project Start
1984-04-01
Project End
2005-04-30
Budget Start
2003-05-01
Budget End
2004-04-30
Support Year
20
Fiscal Year
2003
Total Cost
$431,846
Indirect Cost
Name
University of Colorado Denver
Department
Psychiatry
Type
Schools of Medicine
DUNS #
041096314
City
Aurora
State
CO
Country
United States
Zip Code
80045
Martin, Laura F; Leonard, Sherry; Hall, Mei-Hua et al. (2007) Sensory gating and alpha-7 nicotinic receptor gene allelic variants in schizoaffective disorder, bipolar type. Am J Med Genet B Neuropsychiatr Genet 144B:611-4
Martin, Laura F; Hall, Mei-Hua; Ross, Randal G et al. (2007) Physiology of schizophrenia, bipolar disorder, and schizoaffective disorder. Am J Psychiatry 164:1900-6
Du, Yiping P; Dalwani, Manish; Wylie, Korey et al. (2007) Reducing susceptibility artifacts in fMRI using volume-selective z-shim compensation. Magn Reson Med 57:396-404
Ross, Randal G; Heinlein, Shari; Zerbe, Gary O et al. (2005) Saccadic eye movement task identifies cognitive deficits in children with schizophrenia, but not in unaffected child relatives. J Child Psychol Psychiatry 46:1354-62
Freedman, Robert; Ross, Randal; Leonard, Sherry et al. (2005) Early biomarkers of psychosis. Dialogues Clin Neurosci 7:17-29
Tregellas, Jason R; Tanabe, Jody L; Martin, Laura F et al. (2005) FMRI of response to nicotine during a smooth pursuit eye movement task in schizophrenia. Am J Psychiatry 162:391-3
Olincy, Ann; Martin, Laura (2005) Diminished suppression of the P50 auditory evoked potential in bipolar disorder subjects with a history of psychosis. Am J Psychiatry 162:43-9
Adler, Lawrence E; Olincy, Ann; Cawthra, Ellen M et al. (2004) Varied effects of atypical neuroleptics on P50 auditory gating in schizophrenia patients. Am J Psychiatry 161:1822-8
Tregellas, Jason R; Tanabe, Jody L; Miller, David E et al. (2004) Neurobiology of smooth pursuit eye movement deficits in schizophrenia: an fMRI study. Am J Psychiatry 161:315-21
Freedman, Robert (2003) Schizophrenia. N Engl J Med 349:1738-49

Showing the most recent 10 out of 86 publications